Evidence map›Paper›PMID 26449954›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Bloodstream Infections and Frequency of Pretreatment Associated With Age and Hospitalization Status in Sub-Saharan Africa.

Chelsea Nichols, Ligia Maria Cruz Espinoza, Vera von Kalckreuth, Peter Aaby, Muna Ahmed El Tayeb, Mohammad Ali, Abraham Aseffa, Morten Bjerregaard-Andersen, Robert F Breiman, Leonard Cosmas and 35 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. An Appraisal of the Clinical Features of Pediatric Enteric Fever: Systematic Review and Meta-analysis of the Age-Stratified Disease Occurrence.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  3. Pooled it
  4. Article
  5. Carbapenem-resistantFrontiers in cellular and infection microbiology · 2025
    Article
  6. Article
  7. Article
  8. Severe malaria.Malaria journal · 2022
    Review
  9. High Frequency of Antibiotic Prescription in Children With Undifferentiated Febrile Illness in Kenya.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 20 institutions in 16 countries.

Chelsea NicholsInternational Vaccine Institute, Seoul, Republic of Korea.
Ligia Maria Cruz EspinozaInternational Vaccine Institute, Seoul, Republic of Korea.
Vera von KalckreuthInternational Vaccine Institute, Seoul, Republic of Korea.
Peter AabyBandim Health Project, Bissau, Guinea-Bissau Research Center for Vitamins and Vaccines, Copenhagen, Denmark.
Muna Ahmed El TayebFaculty of Medicine, University of Gezira, Wad Medani, Sudan.
Mohammad AliInternational Vaccine Institute, Seoul, Republic of Korea Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Abraham AseffaArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Morten Bjerregaard-AndersenBandim Health Project, Bissau, Guinea-Bissau Research Center for Vitamins and Vaccines, Copenhagen, Denmark.
Robert F BreimanKenya Medical Research Institute-Center for Global Health Research, Nairobi Global Health Institute, Emory University, Atlanta, Georgia.
Leonard CosmasKenya Medical Research Institute-Center for Global Health Research, Nairobi Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention-Kenya, Nairobi.
John A CrumpDivision of Infectious Diseases and International Health, Duke University Medical Center Duke Global Health Institute, Duke University, Durham, North Carolina Centre for International Health, University of Otago, Dunedin, New Zealand Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Denise Myriam DekkerBernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Amy Gassama SowUniversité Cheikh Anta Diop de Dakar Institut Pasteur de Dakar, Senegal.
Nagla GasmelseedFaculty of Medicine, University of Gezira, Wad Medani, Sudan.
Julian T HertzDivision of Infectious Diseases and International Health, Duke University Medical Center Duke Global Health Institute, Duke University, Durham, North Carolina.
Justin ImInternational Vaccine Institute, Seoul, Republic of Korea.
Leon Parfait KaboreSchiphra Hospital, Ouagadougou, Burkina Faso.
Karen H KeddyNational Institute for Communicable Diseases Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Frank KoningsInternational Vaccine Institute, Seoul, Republic of Korea.
Sandra Valborg LøfbergBandim Health Project, Bissau, Guinea-Bissau Research Center for Vitamins and Vaccines, Copenhagen, Denmark.
Christian G MeyerInstitute of Tropical Medicine, Eberhard-Karls University Tübingen, Germany.
Joel M MontgomeryKenya Medical Research Institute-Center for Global Health Research, Nairobi Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention-Kenya, Nairobi.
Aissatou NiangInstitut Pasteur de Dakar, Senegal.
Andriamampionona NjariharinjakamampiononaUniversity of Antananarivo, Madagascar.
Beatrice OlackKenya Medical Research Institute-Center for Global Health Research, Nairobi.
Gi Deok PakInternational Vaccine Institute, Seoul, Republic of Korea.
Ursula PanznerInternational Vaccine Institute, Seoul, Republic of Korea.
Jin Kyung ParkInternational Vaccine Institute, Seoul, Republic of Korea.
Se Eun ParkInternational Vaccine Institute, Seoul, Republic of Korea.
Henintsoa RabezanaharyUniversity of Antananarivo, Madagascar.
Jean Philibert RakotondrainiariveloUniversity of Antananarivo, Madagascar.
Raphaël RakotozandrindrainyUniversity of Antananarivo, Madagascar.
Tiana Mirana RaminosoaUniversity of Antananarivo, Madagascar.
Matthew P RubachDivision of Infectious Diseases and International Health, Duke University Medical Center.
Mekonnen TeferiArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Hye Jin SeoInternational Vaccine Institute, Seoul, Republic of Korea.
Arvinda SookaNational Institute for Communicable Diseases.
Abdramane SouraInstitut Supérieur des Sciences de la Population, University of Ouagadougou, Burkina Faso.
Adama TallInstitut Pasteur de Dakar, Senegal.
Trevor ToyInternational Vaccine Institute, Seoul, Republic of Korea.
Biruk YeshitelaArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
John D ClemensInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka UCLA Fielding School of Public Health.
Thomas F WierzbaInternational Vaccine Institute, Seoul, Republic of Korea.
Stephen BakerOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Florian MarksInternational Vaccine Institute, Seoul, Republic of Korea.
International Vaccine Institute · KRUniversity of Antananarivo · MGArmauer Hansen Research Institute · ETBandim Health Project · GWKenya Medical Research Institute · KEInstitut Pasteur de Dakar · SNUniversity of Gezira · SDBernhard Nocht Institute for Tropical Medicine · DECenters for Disease Control and Prevention · KECheikh Anta Diop University · SNDuke Institute for Health Innovation · USDuke Medical Center · USDuke University · USFielding Graduate University · USInstitut Superieur Des Sciences De La Population · BFJohns Hopkins University · USNational Center for Communicable Diseases · MNNational Institute for Communicable DiseasesOxford University Clinical Research Unit · VNUniversity of Tübingen · DE

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
Viral and Host Determinants of HIV-1 TransmissionU01AI067854 · NIAID · DUKE UNIVERSITY · PI HAYNES, BARTON F · 2005 to 2005
$14.9M
HIV/AIDS Clinical Trials UnitU01AI069484 · NIAID · DUKE UNIVERSITY · PI BARTLETT, JOHN A · 2007 to 2011
$14.6M
International Clinical Trials UnitU01AI062563 · NIAID · DUKE UNIVERSITY · PI BARTLETT, JOHN A · 2004 to 2007
$4.0M
The Impact and Society Ecology of Bacterial Zoonoses in Northern Tanzania: UnderR01TW009237 · FIC · DUKE UNIVERSITY · PI CRUMP, JOHN ANDREW · 2011 to 2014
$1.7M
Biotechnology and Biological Sciences Research Council BB/J010367FIC NIH HHS R01 TW009237FIC NIH HHS R01TW009237FIC NIH HHS R24 TW007988NIAID NIH HHS P30 AI064518NIAID NIH HHS U01 AI062563NIAID NIH HHS U01 AI067854NIAID NIH HHS U01 AI069484PHS HHS D43 PA-03-018Wellcome Trust 100087Wellcome Trust 100087/Z/12/Z
6 · The paper itself

Abstract

backgroundThe clinical diagnosis of bacterial bloodstream infections (BSIs) in sub-Saharan Africa is routinely confused with malaria due to overlapping symptoms. The Typhoid Surveillance in Africa Program (TSAP) recruited febrile inpatients and outpatients of all ages using identical study procedures and enrollment criteria, thus providing an opportunity to assess disease etiology and pretreatment patterns among children and adults.

methodsInpatients and outpatients of all ages with tympanic or axillary temperatures of ≥38.0 or ≥37.5°C, respectively, and inpatients only reporting fever within the previous 72 hours were eligible for recruitment. All recruited patients had one blood sample drawn and cultured for microorganisms. Data from 11 TSAP surveillance sites in nine different countries were used in the analysis. Bivariate analysis was used to compare frequencies of pretreatment and BSIs in febrile children (<15 years old) and adults (≥15 years old) in each country. Pooled Cochran Mantel-Haenszel odds ratios (ORs) were calculated for overall trends.

resultsThere was no significant difference in the odds of a culture-proven BSI between children and adults among inpatients or outpatients. Among both inpatients and outpatients, children had significantly higher odds of having a contaminated blood culture compared with adults. Using country-pooled data, child outpatients had 66% higher odds of having Salmonella Typhi in their bloodstream than adults (OR, 1.66; 95% confidence interval [CI], 1.01-2.73). Overall, inpatient children had 59% higher odds of pretreatment with analgesics in comparison to inpatient adults (OR, 1.59; 95% CI, 1.28-1.97).

conclusionsThe proportion of patients with culture-proven BSIs in children compared with adults was similar across the TSAP study population; however, outpatient children were more likely to have Salmonella Typhi infections than outpatient adults. This finding points to the importance of including outpatient facilities in surveillance efforts, particularly for the surveillance of typhoid fever. Strategies to reduce contamination among pediatric blood cultures are needed across the continent to prevent the misdiagnosis of BSI cases in children.

Indexed as

AdolescentAdultAfrica South of the SaharaAge FactorsBacteremiaChildChild, PreschoolFemaleFeverHospitalizationHumansInpatientsMalariaMaleOutpatientsPrevalencebloodstream infectionshospitalizationpretreatmentsub-Saharan Africa

Identifiers

PMID26449954
PMCPMC4596935
OpenAlexW2272982049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.